SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-117911
Filing Date
2011-04-29
Accepted
2011-04-29 13:08:51
Documents
9
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 631216
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9418
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9403
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 3172
  Complete submission text file 0001193125-11-117911.txt   3006347

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bmrn-20110331.xml EX-101.INS 500048
6 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20110331.xsd EX-101.SCH 15952
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20110331_cal.xml EX-101.CAL 37554
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20110331_lab.xml EX-101.LAB 128917
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20110331_pre.xml EX-101.PRE 82793
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 11792802
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1